Cite
MLA Citation
U. Syrbe et al.. “SAT0371 Ustekinumab Treatment in Ankylosing Spondylits (AS) Patients Does not Modulate Effector CD4+ T Cell Frequencies Including TH17 Cells.” Annals of the rheumatic diseases, vol. 73, 2014, pp. 727–728. http://access.bl.uk/ark:/81055/vdc_100135132226.0x000059